In 2006, the South Korean Ministry of Science and Technology selected the KIST and Purdue team project from 20 international research proposals submitted to examine how to learn more about the molecular makeup of diseases.
The $4.5 million research initiative, which spans nine years, now involves more than a dozen of KIST and Purdue researchers, working to advance the role that nanoparticles can play in the diagnosis and treatment of cancer or chronic diseases like diabetes and multiple sclerosis.
The research also focuses on next-generation tools that would aid the medical community in what's known as theragnosis -- combining simultaneous diagnostics and therapeutics.
Cite this work
Researchers should cite this work as follows:
Burton Morgan 121, Purdue University, West Lafayette, IN
- biomedical engineering